Description: Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.
Home Page: www.canopygrowth.com
CGC Technical Analysis
1 Hershey Drive
Smiths Falls,
ON
K7A 0A8
Canada
Phone:
855 558 9333
Officers
| Name | Title |
|---|---|
| Mr. David Eric Klein | CEO & Director |
| Ms. Judy Eunjoo Hong | VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO |
| Mr. Julious C. Grant Jr. | Chief Commercial Officer |
| Mr. Jonathan Di Tosto | Chief Operations Officer |
| Mr. Thomas Carlton Stewart | VP & Chief Accounting Officer |
| Mr. Thomas Shipley IV | Sr. VP of Quality Assurance & Chief Science Officer |
| Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Legal Officer |
| Mr. Timothy Rob Saunders F.C.A., FCPA | Strategic Advisor |
| Jason Green | Head of Agriculture - Hemp Division |
| Dr. Mark A. Ware | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.167 |
| Price-to-Sales TTM: | 2.6555 |
| IPO Date: | 2014-04-04 |
| Fiscal Year End: | March |
| Full Time Employees: | 3151 |